Skin biopsy: A useful tool in the diagnosis of lysosomal storage diseases

Ultrastructural Pathology

Volumn 30, Issue 6, 2006, Pages 489-503

  Alroy, Joseph ^a,b   Ucci, Angelo A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Electron microscopy; Lysosomal storage disease

Indexed keywords

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; ELECTRON MICROSCOPY; ENZYME ASSAY; HUMAN; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOLIPIDOSIS; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; SCREENING; SKIN BIOPSY;

BIOPSY; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LYSOSOMAL STORAGE DISEASES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; SKIN;

EID: 33845892119     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120500520986     Document Type: Article

References (41)

1. Reuser AJJ, Kroos MA, Visser WJ, Willemsen R. Lysosomal storage diseases: cellular pathology, clinical and genetic heterogeneity, therapy. Ann Biol Chem. 1994;52:721-728.
2. Wenger DA, Coppola S, Liu S-L. Insight into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol. 2003;60:322-328.
3. Neufeld EF. Natural history and inherited disorders of lysosomal enzyme, β-hexosaminidase. J Biol Chem. 1989;264:10927-10930.
4. Merin S, Livni N, Berman ER, Yatziv S. Mucolipidosis, IV: ocular, systemic and ultrastructural findings. Invest Ophthalmol. 1975;14:437-448.
5. Ushiyama M, Ikeda S-I, Nakayama J, et al. Type III (chronic) GMI-gangliosidosis, histochemical and ultrastructural studies of rectal biopsy. J Neurol Sci. 1985;71:209-223.
6. Belcher RW. Ultrastructure of the skin in the genetic mucopolysccharidoses. Arch Pathol. 1972;94:511-518.
7. Taniike M, Yamano T, Shimada M, Inui K, Okada S. Ultrastructural pathology of rectum and skin biopsy specimens in lysosomal storage diseases. Acta Histochem Cytochem. 1990; 23:81-92.
8. Holbrook KA, Byers PH. Skin is a window on heritable disorders of connective tissue. Am J Med Genet. 1989;34:105-121.
9. Ono S, Waring SC, Kurland LL, Katrina-Craig U, Petersen RC. Guamanian neurodegenerative disease: ultrastructural studies of skin. J Neurol Sci. 1997:146:35-40.
10. Ruchoux M-M, Maurage C-A. Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol. 1997;23:60-65.
11. Prasad A, Kaye EM, Alroy J. Electron microscopic examination of skin biopsies as a cost-effective tool in the diagnosis of lysosomal storage diseases. J Child Neurol. 1996;II:301-308.
12. Smithson SF, Winter RM. Diagnosis in dysmorphology: clue from the skin. Br J Dermatol. 2004;151:953-960.
13. Natowicz MR, Short MP, Wang Y, et al. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med. 1996;335:1029-1033.
14. Dvorak AN, Cable WJL, Osage JE, Kolodny EH. Diagnostic electron microscopy, II: Fabry's disease: use of biopsies from uninvolved skins: acute and chronic changes involving the microvsaculature and small unmyelinated nerves. Pathol Annu. 1981;16:139-158.
15. Vracko R, Benditt EP. Manifestation of diabetes mellitus-their possible relationships to an underlying cell defect. Am J Pathol. 1974;75:204-224.
16. Ohnishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease: histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol. 1974;31:120-127.
17. Valeriani M, Mariotti P, La Pera D, et al. Functional assessment of Ad and C fibers in patients with Fabry's disease. Muscle Nerve. 2004:30;708-713.
18. Boustany R-MN, Kayes E, Alroy J. Ultrastructural findings in skin from patients with Niemann-Pick disease, type C. Pediatr Neurol. 1990;6:177-183.
19. Klein D, BUS sow H, Fewer SG, Tiedemann V. Exocytosis of storage material in a lysosomal disorders. Biochem Biopsys Res Commun. 2005;327:663-667.
20. Castagnaro M, Alroy J, Ucci AA, Glew RH. Lectin histochemistry and ultrastructure of feline kidney from, six different storage diseases. Virchows Arch B Cell Pathol. 1987;54:16-26.
21. Gelb BD, Bromme D, Desnick RJ. Pycnodysostosis: cathepsin K deficiency. In: Scriver R, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Base of Inherited Diseases, ed 8. New York: McGraw-Hill; 2001:3453-3468.
22. Evert V, Aronson DC, Beertsen W. Phagocytosis of bone collagen by osetoclasts in two cases of pycnodysostosis. Calcif Tissue Int. 1985;37:25-31.
23. Goebel HH, Kimura S, Harzer K, Klein H. Ultrastructural pathology of eccrine sweat gland epithelial cells in globoid cells leukodystrophy. J Child Neurol. 1993;8:171-174.
24. Avila JL, Convit J. Inhibition of leukocytes lysosomal enzymes by glycosaminoglycans in vitro. Biochem J. 1975;152:57-64.
25. Roytta M, Fagerlund AS, Toikkanen S, et al. Wolman disease: morphological, clinical and genetic studies on the first Scandinavian cases. Clin Genet. 1992; 42:1-7.
26. Burck U, Moser HW, Goebel HH, et al. A case of lipogranulomatosis Farber: some clinical and ultrstructural aspects. Eur J Pediatr. l985;143:203-208.
27. Vogler C, Rosenberg HS, Williams JC, Butler I. Electron microscopy in the diagnosis of lysosomal storage disease. Am J Med Genet. 1987;3:243-255.
28. Wan WL, Minckler DS, Rao NA. Pupillary-block glaucoma associated with childhood cystinosis. Am J Ophthalmol. 1986;101:700-705.
29. Shulz A, Dhar S, Rylova S, et al. Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann Neurol. 2004;56:342-350.
30. Ezaki J, Kominami E. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol. 2004;14:77-85.
31. Wisniewski KE, Zhong N, Philippart M. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses. Neurology 2001;57:576-581.
32. Rapola J. Neuronal ceroid lipofuscinoses in childhood. In: Landing BH, Haust MD, Bernstein J, Rosenberg HS, et al, eds. Genetic Metabolic Diseases: Perspect Pediatr Pathol. Basel: S Krager; 1993:17:7-44.
33. Nijssen PCG, Ceuteric C, van Diggelen OP, et al. Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency. Brain Pathol. 2003;13:574-581.
34. Duchen LW. General pathology of neurons and neuroglia. In: Adams JH, Duchen LW, eds. Greenfeld's Neuropathology, ed 5. New York: Oxford University Press; 1992:1-68.
35. Walkley SU, Wurzelmann S. Alterations in synaptic connectivity in cerebral cortex in neuronal storage disorders. Ment Retard Dev Disabil Res Rev. 1995;1:183-192.
36. Beutler E, Grabowski GA. Gaucher disease. In: Scriver R, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Base of Inherited Disease, ed 8. New York: McGraw-Hill; 2001:3635-3668.
37. Sidransky E, Fartasch M, Lee RE, Metlay LA, et al. Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res. 1996;39:134-141.
38. Navarro C, Fachal C, Rodriguez C, Padro L, Dominguez C. Lipoid proteinosis: a biochemical and ultrastructural investigation of two new cases. Br J Dermatol. 1999;141:326-331.
39. Elias PM, Williams ML. Neutral lipid storage with ichthyosis, defective lamellar body contents and intracellular dispersion. Arch Dermatol. 1985;121:1000-1008.
40. Hruban Z. Pulmonaiy and generalized lysosomal storage induced by amphophilic drug. Environ Health Perspect. 1984;55:53-76.
41. Vallance H, Chaba T, Clarke L, Taylor G. Pseudo-lysosomal storage disease caused by EMLA cream. J Inherit Metab Dis. 2004;27:507-511.